SCHEMBL4024441

SCHEMBL4024441

CNc1nc(C(C)C(=O)OCC(C)C)c(C#N)c(-c2ccc3c(c2)OCO3)c1C#N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 9/20 0.46
ADORA2A P29274 3/20 0.46
TSHR P16473 2/20 0.40
ALOX15 P16050 2/20 0.40
ALDH1A1 P00352 7/20 0.39
KDM4E B2RXH2 6/20 0.39
MAPT P10636 4/20 0.39
GAA P10253 4/20 0.39
NPC1 O15118 4/20 0.39
HPGD P15428 5/20 0.39
NPSR1 Q6W5P4 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
RAB9A P51151 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
ADORA2B P29275 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HSD17B10 Q99714 2/20 0.38
POLB P06746 1/20 0.38
ALOX12 P18054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4026430 0.92 ADORA1 (0.46) ADORA1ADORA2AALOX15ALDH1A1KDM4E
SCHEMBL4022211 0.79 ADORA1 (0.58) ADORA1ADORA2ATSHRALOX15ALDH1A1
SCHEMBL4023617 0.79 ADORA1 (0.63) ADORA1ADORA2ATSHRALOX15ALDH1A1
SCHEMBL4024199 0.76 ADORA1 (0.55) ADORA1ADORA2ATSHRALOX15ALDH1A1
SCHEMBL4025782 0.76 ADORA1 (0.59) ADORA1ADORA2ATSHRALOX15ALDH1A1
SCHEMBL13848826 0.75 ADORA1 (0.56) ADORA1ADORA2ATSHRALOX15ALDH1A1
SCHEMBL5951299 0.75 ADORA1 (0.46) ADORA1ADORA2AALOX15ALDH1A1KDM4E
SCHEMBL4191367 0.73 ADORA1 (0.51) ADORA1ADORA2ATSHRALOX15ALDH1A1
SCHEMBL6583277 0.73 ADORA1 (0.61) ADORA1ADORA2ATSHRALOX15ALDH1A1
SCHEMBL4028154 0.73 ADORA1 (0.56) ADORA1ADORA2ATSHRALOX15ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1377570-B1 SUBSTITUTED 2-CARBA-3,5-DICYANO-4-ARYL-6-AMINOPYRIDINES AND THE USE OF THE SAME AS SELECTIVE LIGANDS OF THE ADENOSINE RECEPTOR BAYER HEALTHCARE AG (DE) 2009-05-13 EP disclosed
US-7129255-B2 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor BAYER AKTIENGESELLSCHAFT (DE) 2006-10-31 US disclosed
US-20040110946-A1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2004-06-10 US disclosed
EP-1377570-A1 SUBSTITUTED 2-CARBA-3,5-DICYANO-4-ARYL-6-AMINOPYRIDINES AND THE USE OF THE SAME AS SELECTIVE LIGANDS OF THE ADENOSINE RECEPTOR Bayer HealthCare AG (DE) 2004-01-07 EP disclosed
WO-2002079196-A1 SUBSTITUTED 2-CARBA-3,5-DICYANO-4-ARYL-6-AMINOPYRIDINES AND THE USE OF THE SAME AS SELECTIVE LIGANDS OF THE ADENOSINE RECEPTOR BAYER AKTIENGESELLSCHAFT (DE) 2002-10-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110946-A1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor ADORA3, ADORA1, ADORA2A ADORA1 2/4885ADORA2A 3/4885TSHR 349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.